Format

Send to

Choose Destination
PLoS One. 2014 Sep 4;9(9):e106912. doi: 10.1371/journal.pone.0106912. eCollection 2014.

Erythrocyte phospholipid and polyunsaturated fatty acid composition in diabetic retinopathy.

Author information

1
Department of Ophthalmology, University Hospital, Dijon, France.
2
INRA, UMR1324 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; CNRS, UMR6265 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; Université de Bourgogne, UMR Centre des Sciences du Goût et de l'Alimentation, Dijon, France.
3
Department of Ophthalmology, University Hospital, Dijon, France; INRA, UMR1324 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; CNRS, UMR6265 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; Université de Bourgogne, UMR Centre des Sciences du Goût et de l'Alimentation, Dijon, France.

Abstract

BACKGROUND:

Long chain polyunsaturated fatty acids (LCPUFAs) including docosahexaenoic acid and arachidonic acid are suspected to play a key role in the pathogenesis of diabetes. LCPUFAs are known to be preferentially concentrated in specific phospholipids termed as plasmalogens. This study was aimed to highlight potential changes in the metabolism of phospholipids, and particularly plasmalogens, and LCPUFAs at various stages of diabetic retinopathy in humans.

METHODOLOGY AND PRINCIPAL FINDINGS:

We performed lipidomic analyses on red blood cell membranes from controls and mainly type 2 diabetes mellitus patients with or without retinopathy. The fatty acid composition of erythrocytes was determined by gas chromatography and the phospholipid structure was determined by liquid chromatography equipped with an electrospray ionisation source and coupled with a tandem mass spectrometer (LC-ESI-MS/MS). A significant decrease in levels of docosahexaenoic acid and arachidonic acid in erythrocytes of diabetic patients with or without retinopathy was observed. The origin of this decrease was a loss of phosphatidyl-ethanolamine phospholipids esterified with these LCPUFAs. In diabetic patients without retinopathy, this change was balanced by an increase in the levels of several phosphatidyl-choline species. No influence of diabetes nor of diabetic retinopathy was observed on the concentrations of plasmalogen-type phospholipids.

CONCLUSIONS AND SIGNIFICANCE:

Diabetes and diabetic retinopathy were associated with a reduction of erythrocyte LCPUFAs in phosphatidyl-ethanolamines. The increase of the amounts of phosphatidyl-choline species in erythrocytes of diabetic patients without diabetic retinopathy might be a compensatory mechanism for the loss of LC-PUFA-rich phosphatidyl-ethanolamines.

PMID:
25188352
PMCID:
PMC4154797
DOI:
10.1371/journal.pone.0106912
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center